Category : Search result: oncology drugs


Indian Pharma Firms Eye Licensing Deals for Obesity Drugs

As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.

Bengaluru engineer arrested for making drugs at home

A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.

Mumbai's Cancer Care Sector Becomes Fastest Growing

Mumbai's private hospitals see oncology as the fastest-growing healthcare sector, driven by rising cases and investments in advanced tech like robots and linear accelerators. Explore the boom and its challenges.

GLP-1 Drugs Show Benefits Beyond Weight Loss

New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.

Lack of Drug Inspectors Hampers Action on Spurious Drugs

A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.

Himachal Leads Nation in Substandard Drugs: 49 Fail

Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.

India's Cancer Care Crisis: A Patient's Journey & Solutions

Medha's stage III cervical cancer diagnosis reveals systemic gaps in India's oncology. With 2M new cases yearly, only 30% are caught early. Discover how decentralized care, tech, and patient-centric models can transform outcomes.

Page 1 of 4